Author

S. Sedimbi

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Research Focus:cell type annotation· 2 Research Focus:drug response / drug discovery· 2 Research Focus:cancer & tumor microenvironment· 1 Assay:CRISPR screen· 1 Research Focus:differential expression· 1 Organism:E. coli· 1

Frequent Co-Authors

D. P. Lane· 3 shared B. Vojtesek· 2 shared F. Wermeling· 2 shared K. Ingelshed· 2 shared L. Jiang· 2 shared A. Lerma Clavero· 1 shared A. Rising· 1 shared A. S. Ng· 1 shared

Activity by Year

2021-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

D. P. Lane

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

MDM2 inhibitors, nutlin-3a and navtemadelin, retain efficacy in human and mouse cancer cells cultured in hypoxia

A. Lerma Clavero, P. Lafqvist Boqvist, K. Ingelshed, C. Bosdotter, S. Sedimbi, L. Jiang, F. Wermeling, B. Vojtesek, D. P. Lane, P. Kannan

This study shows that MDM2 inhibitors nutlin-3a and navtemadelin remain effective in hypoxic conditions in human and mouse cancer cells with wild-type p53, but not in mutant or null p53 cells.

bioRxiv · Oct 20, 2022Cancer Biology

CRISPR enriches for cells with mutations in a p53-related interactome, and this can be inhibited.

L. Jiang, K. Ingelshed, Y. Shen, S. V. Boddul, V. S. Iyer, Z. Kasza, S. Sedimbi, D. P. Lane, F. Wermeling

The paper shows that CRISPR enriches cells with p53-related mutations and demonstrates that transient p53 inhibition can suppress this effect.

bioRxiv · Mar 10, 2021 · PreprintCancer Biology

A spindle and thread-mechanism unblocks translation of N-terminally disordered proteins

M. Kaldmae, T. Vosselman, X. Zhong, D. Lama, G. Chen, M. Saluri, N. Kronqvist, J. W. Siau, A. S. Ng, F. J. Ghadessy, P. Sabatier, B. Vojtesek, M. Sarr, C. Sahin, N. Osterlund, , M. Landreh

This study shows that fusing disordered proteins to an engineered spider silk domain improves their translation efficiency and activity in cells.

bioRxiv · Feb 22, 2021 · PreprintBiochemistry